Cornerstone Advisors (Washington)’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$3K Hold
35
﹤0.01% 539
2020
Q2
$3K Sell
35
-80
-70% -$5.57K ﹤0.01% 541
2020
Q1
$7K Buy
115
+35
+44% +$3.23K ﹤0.01% 447
2019
Q4
$9K Hold
80
﹤0.01% 434
2019
Q3
$8K Buy
80
+48
+150% +$4.51K ﹤0.01% 432
2019
Q2
$3K Buy
32
+10
+45% +$822 ﹤0.01% 1024
2019
Q1
$2K Buy
+22
New +$1.6K ﹤0.01% 986

Other funds holding CNMD

Cornerstone Advisors (Washington)'s CNMD Position: Q3 2020 in Review

Cornerstone Advisors (Washington) held its CONMED (CNMD) position steady in Q3 2020 at 35 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Cornerstone Advisors (Washington) first reported a position in CNMD in Q1 2019 and has held it in 7 quarters since. The position peaked at $9K in Q4 2019. 240 funds tracked by Wall St. Rank hold CNMD as of Q3 2020.

  • Cornerstone Advisors (Washington) held 35 shares of CONMED worth $3K as of Q3 2020.
  • Cornerstone Advisors (Washington) left its CONMED share count unchanged in Q3 2020.
  • CONMED made up ﹤0.01% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #539 holding.
  • Cornerstone Advisors (Washington) first reported a position in CONMED in Q1 2019 and has held it in 7 quarters since.
  • Cornerstone Advisors (Washington)'s CONMED position peaked at $9K in Q4 2019.
  • 240 funds tracked by Wall St. Rank held CONMED as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.